MITOMICINA C NEL TRATTAMENTO DEI SARCOMI DEI TESSUTI MOLLI DELL'ADULTO IN FASE AVANZATA

Translated title of the contribution: Mitomycin C in treatment of advanced soft-tissue sarcomata in adults

L. Di Lauro, A. Balice, P. Papaldo, M. Lopez

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Mitomycin C at a dose of 20 mg/m2 i.v. every 6 weeks was administered to 15 evaluable patients with measurable advanced soft tissue sarcomas resistant to standard treatment. No response was observed. Disease stabilization occurred in 5 patients, with a median duration of 4 months. Toxicity was generally mild to moderate. On the basis of this study, mitomycin C, in the dosage and schedule used in the above study, cannot be recommended in the treatment of this disease.

Original languageItalian
Pages (from-to)83-85
Number of pages3
JournalClinica Terapeutica
Volume115
Issue number2
Publication statusPublished - 1985

Fingerprint

Mitomycin
Sarcoma
Appointments and Schedules
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Di Lauro, L., Balice, A., Papaldo, P., & Lopez, M. (1985). MITOMICINA C NEL TRATTAMENTO DEI SARCOMI DEI TESSUTI MOLLI DELL'ADULTO IN FASE AVANZATA. Clinica Terapeutica, 115(2), 83-85.

MITOMICINA C NEL TRATTAMENTO DEI SARCOMI DEI TESSUTI MOLLI DELL'ADULTO IN FASE AVANZATA. / Di Lauro, L.; Balice, A.; Papaldo, P.; Lopez, M.

In: Clinica Terapeutica, Vol. 115, No. 2, 1985, p. 83-85.

Research output: Contribution to journalArticle

Di Lauro, L, Balice, A, Papaldo, P & Lopez, M 1985, 'MITOMICINA C NEL TRATTAMENTO DEI SARCOMI DEI TESSUTI MOLLI DELL'ADULTO IN FASE AVANZATA', Clinica Terapeutica, vol. 115, no. 2, pp. 83-85.
Di Lauro, L. ; Balice, A. ; Papaldo, P. ; Lopez, M. / MITOMICINA C NEL TRATTAMENTO DEI SARCOMI DEI TESSUTI MOLLI DELL'ADULTO IN FASE AVANZATA. In: Clinica Terapeutica. 1985 ; Vol. 115, No. 2. pp. 83-85.
@article{1edf2d808cb14273b92379483cc05cf2,
title = "MITOMICINA C NEL TRATTAMENTO DEI SARCOMI DEI TESSUTI MOLLI DELL'ADULTO IN FASE AVANZATA",
abstract = "Mitomycin C at a dose of 20 mg/m2 i.v. every 6 weeks was administered to 15 evaluable patients with measurable advanced soft tissue sarcomas resistant to standard treatment. No response was observed. Disease stabilization occurred in 5 patients, with a median duration of 4 months. Toxicity was generally mild to moderate. On the basis of this study, mitomycin C, in the dosage and schedule used in the above study, cannot be recommended in the treatment of this disease.",
author = "{Di Lauro}, L. and A. Balice and P. Papaldo and M. Lopez",
year = "1985",
language = "Italian",
volume = "115",
pages = "83--85",
journal = "Clinica Terapeutica",
issn = "0009-9074",
publisher = "Societa Editrice Universo",
number = "2",

}

TY - JOUR

T1 - MITOMICINA C NEL TRATTAMENTO DEI SARCOMI DEI TESSUTI MOLLI DELL'ADULTO IN FASE AVANZATA

AU - Di Lauro, L.

AU - Balice, A.

AU - Papaldo, P.

AU - Lopez, M.

PY - 1985

Y1 - 1985

N2 - Mitomycin C at a dose of 20 mg/m2 i.v. every 6 weeks was administered to 15 evaluable patients with measurable advanced soft tissue sarcomas resistant to standard treatment. No response was observed. Disease stabilization occurred in 5 patients, with a median duration of 4 months. Toxicity was generally mild to moderate. On the basis of this study, mitomycin C, in the dosage and schedule used in the above study, cannot be recommended in the treatment of this disease.

AB - Mitomycin C at a dose of 20 mg/m2 i.v. every 6 weeks was administered to 15 evaluable patients with measurable advanced soft tissue sarcomas resistant to standard treatment. No response was observed. Disease stabilization occurred in 5 patients, with a median duration of 4 months. Toxicity was generally mild to moderate. On the basis of this study, mitomycin C, in the dosage and schedule used in the above study, cannot be recommended in the treatment of this disease.

UR - http://www.scopus.com/inward/record.url?scp=0022380137&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022380137&partnerID=8YFLogxK

M3 - Articolo

VL - 115

SP - 83

EP - 85

JO - Clinica Terapeutica

JF - Clinica Terapeutica

SN - 0009-9074

IS - 2

ER -